Annotating human genes: where do we stand now?
In a perspective article published in Nature, Piero Carninci and colleagues discuss the status of human gene annotation and how high-throughput RNA sequencing technologies have accelerated the discovery of non-coding RNA genes with unknown functions and will promote the completion of the human gene catalogue.
Mapping the location of human genes and understanding their function is essential for investigating human evolution and gene-disease associations. International consortia such as the Human Genome Project (HGP) and the Telomere-to-Telomere (T2T) have contributed to mapping the human genome sequence over the past 20 years and to identifying thousands of protein-coding genes. This has been facilitated by new high-throughput RNA sequencing technologies that also enabled the identification of numerous non-coding RNA genes (ncRNAs), which are not translated into proteins but rather possess regulatory functions.
Piero Carninci – Head of the Functional Genomics Research Centre at Human Technopole (HT) – and Steven Salzberg – Director of the Center for Computational Biology at Johns Hopkins University (USA) – organised a meeting at The Banbury Center (Cold Spring Harbor Laboratories, USA) where major experts in the field gathered to review the progress made so far towards obtaining a complete list of human genes and to discuss the technology needed to complete gene annotation. The outcome of the discussion is summarised in an article that is now published in the international journal Nature.
The researchers propose several steps to complete the annotation of protein-coding genes in the coming years, including the identification of gene isoforms and pseudogenes. They also discuss the role of new technologies in expanding the list of non-coding RNA genes (one of the main goals of the Carninci Group at HT) and in the functional annotation thereof and emphasise the importance of identifying medically important genes and gene variants and their association with specific disorders. Finally, they also advocate that adopting a standardised description of disease-associated genetic variants would help avoid inconsistencies and misunderstandings in the field.
Finally, Carninci and colleagues suggest that exploring the genomic landscape of different human populations – the so-called human pangenome reference, an international project to which HT researchers from the Population and Medical Genomics Research Centre are also contributing – will provide a more comprehensive view of the gene content of our genome.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.